Monitoring of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography

Launched by UNIVERSITY OF ERLANGEN-NÜRNBERG MEDICAL SCHOOL · Oct 24, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how a special imaging technique called multispectral optoacoustic tomography (MSOT) can be used to monitor the intestinal walls of children with Crohn's disease and ulcerative colitis, which are types of inflammatory bowel diseases. By looking at the "optoacoustic signal" from the intestines, researchers want to understand how this signal changes over time and in response to treatment. This information could help doctors better track the disease and its response to therapy.

To participate in this trial, children aged 2 to 18 who have been diagnosed with or are suspected of having Crohn's disease or ulcerative colitis may be eligible. Parents or legal guardians will need to provide written consent for their child to join. During the study, participants will undergo imaging tests using MSOT, which are designed to be safe and non-invasive. It's important to note that certain individuals, such as those who are pregnant or have specific health issues, will not be able to participate. Overall, this trial aims to improve how we monitor and treat these conditions in children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Existing diagnosis of CD or UC, or suspected CD or UC at initial diagnosis.
• • Age 2 - 18 years
• • Written declaration of consent from parents / legal guardians
• Exclusion Criteria:
• • Pregnancy
• • Nursing mothers
• • Cardiopulmonary unstable patients\*: Need for continuous cardiopulmonary monitoring
• • Tattoo in the area of the examination field
• • Subcutaneous fat \> 3 cm